1. Home
  2. AUPH vs SDA Comparison

AUPH vs SDA Comparison

Compare AUPH & SDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AUPH
  • SDA
  • Stock Information
  • Founded
  • AUPH 1993
  • SDA 2007
  • Country
  • AUPH Canada
  • SDA China
  • Employees
  • AUPH N/A
  • SDA N/A
  • Industry
  • AUPH Biotechnology: Pharmaceutical Preparations
  • SDA Blank Checks
  • Sector
  • AUPH Health Care
  • SDA Finance
  • Exchange
  • AUPH Nasdaq
  • SDA Nasdaq
  • Market Cap
  • AUPH 1.1B
  • SDA 263.8M
  • IPO Year
  • AUPH 1999
  • SDA N/A
  • Fundamental
  • Price
  • AUPH $8.86
  • SDA $2.39
  • Analyst Decision
  • AUPH Strong Buy
  • SDA Buy
  • Analyst Count
  • AUPH 2
  • SDA 1
  • Target Price
  • AUPH $11.50
  • SDA $3.50
  • AVG Volume (30 Days)
  • AUPH 2.0M
  • SDA 88.5K
  • Earning Date
  • AUPH 07-31-2025
  • SDA 05-19-2025
  • Dividend Yield
  • AUPH N/A
  • SDA N/A
  • EPS Growth
  • AUPH N/A
  • SDA N/A
  • EPS
  • AUPH 0.27
  • SDA N/A
  • Revenue
  • AUPH $247,295,000.00
  • SDA $458,905,000.00
  • Revenue This Year
  • AUPH $12.15
  • SDA $20.77
  • Revenue Next Year
  • AUPH $18.31
  • SDA $19.32
  • P/E Ratio
  • AUPH $33.08
  • SDA N/A
  • Revenue Growth
  • AUPH 29.20
  • SDA 24.15
  • 52 Week Low
  • AUPH $5.20
  • SDA $2.35
  • 52 Week High
  • AUPH $10.67
  • SDA $11.74
  • Technical
  • Relative Strength Index (RSI)
  • AUPH 64.10
  • SDA 36.04
  • Support Level
  • AUPH $7.36
  • SDA $2.35
  • Resistance Level
  • AUPH $9.10
  • SDA $2.59
  • Average True Range (ATR)
  • AUPH 0.44
  • SDA 0.15
  • MACD
  • AUPH 0.10
  • SDA -0.01
  • Stochastic Oscillator
  • AUPH 89.53
  • SDA 11.43

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

About SDA SunCar Technology Group Inc.

SunCar Technology Group Inc operates digital automotive aftersales market service platform and vehicle insurance technology platform. It develops and operates online platforms that connect drivers in China with a range of aftermarket automotive services and insurance coverage options from a nationwide network of service providers. These comprehensive digital systems are built on SunCar's multi-tenant, cloud-based platform.

Share on Social Networks: